Dr. Wong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
160 East 34th Street
8th Floor
New York, NY 10016Phone+1 212-731-5662- Is this information wrong?
Summary
- Dr. Kwok Kin Wong is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital, and North Shore Medical Center. He received his medical degree from Columbia University College of Physicians & Surgeons and has been in practice 21 years. He specializes in hematologic oncology.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1998 - 2001
- Massachusetts General HospitalResidency, Internal Medicine, 1996 - 1998
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1996
Certifications & Licensure
- MA State Medical License 1998 - 2025
- NY State Medical License 2016 - 2024
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2008
Publications & Presentations
PubMed
- EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation.Qin, Z., Yue, M., Tang, S., Wu, F., Sun, H., Li, Y., Zhang, Y., Izumi, H., Huang, H., Wang, W., Xue, Y., Tong, X., Mori, S., Taki, T., Goto, K., Jin, Y., Li, F., Li, F...> ;The Journal of Experimental Medicine. 2024 Mar 4
- Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC paralogs.Shreoshi Pal Choudhuri, Luc Girard, Jun Yi Stanley Lim, Jillian F Wise, Braeden Freitas, Di Yang, Edmond Wong, Seth Hamilton, Victor D Chien, Yoon Jung Kim, Collin Gil...> ;Cancer Discovery. 2024 Feb 22
- Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer.Xinyuan Tong, Ayushi S Patel, Eejung Kim, Hongjun Li, Yueqing Chen, Shuai Li, Shengwu Liu, Julien Dilly, Kevin S Kapner, Ningxia Zhang, Yun Xue, Laura Hover, Suman Muk...> ;Cancer Cell. 2024 Mar 11
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: